Literature DB >> 26268988

Comparing equals when evaluating immunotherapy with different doses and fractions of radiation therapy.

Michael J Gough1, Marka R Crittenden1,2, Kristina H Young1,2.   

Abstract

Keywords:  SBRT; cancer; dose; fractionation; immunotherapy; radiation; tumor

Mesh：

Year:  2015        PMID： 26268988     DOI： 10.2217/IMT.15.58

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  7 in total

1.  Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16+ cancer.

Authors:  Ugur Sahin; Fulvia Vascotto; Nadja Salomon; Abderaouf Selmi; Christian Grunwitz; Anthony Kong; Eliana Stanganello; Jennifer Neumaier; Jutta Petschenka; Mustafa Diken; Sebastian Kreiter; Özlem Türeci
Journal:  Cancer Immunol Immunother       Date:  2021-12-31       Impact factor: 6.630

2.  A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma.

Authors:  Todd Crocenzi; Benjamin Cottam; Pippa Newell; Ronald F Wolf; Paul D Hansen; Chet Hammill; Matthew C Solhjem; Yue-Yun To; Amy Greathouse; Garth Tormoen; Zeljka Jutric; Kristina Young; Keith S Bahjat; Michael J Gough; Marka R Crittenden
Journal:  J Immunother Cancer       Date:  2016-08-16       Impact factor: 13.751

Review 3.  Defining Immunogenic and Radioimmunogenic Tumors.

Authors:  Terry R Medler; Tiffany C Blair; Marka R Crittenden; Michael J Gough
Journal:  Front Oncol       Date:  2021-03-19       Impact factor: 6.244

4.  Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma.

Authors:  Rom Leidner; Marka Crittenden; Kristina Young; Hong Xiao; Yaping Wu; Marcus A Couey; Ashish A Patel; Allen C Cheng; Amber L Watters; Carlo Bifulco; George Morris; Lessli Rushforth; Shorin Nemeth; Walter J Urba; Michael Gough; R Bryan Bell
Journal:  J Immunother Cancer       Date:  2021-05       Impact factor: 13.751

5.  ICOS is upregulated on T cells following radiation and agonism combined with radiation results in enhanced tumor control.

Authors:  Tiffany Blair; Jason Baird; Shelly Bambina; Gwen Kramer; Monica Gostissa; Christopher J Harvey; Michael J Gough; Marka R Crittenden
Journal:  Sci Rep       Date:  2022-09-02       Impact factor: 4.996

6.  Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity.

Authors:  Marka R Crittenden; Lauren Zebertavage; Gwen Kramer; Shelly Bambina; David Friedman; Victoria Troesch; Tiffany Blair; Jason R Baird; Alejandro Alice; Michael J Gough
Journal:  Sci Rep       Date:  2018-05-03       Impact factor: 4.379

7.  A liposomal RNA vaccine inducing neoantigen-specific CD4+ T cells augments the antitumor activity of local radiotherapy in mice.

Authors:  Nadja Salomon; Fulvia Vascotto; Abderaouf Selmi; Mathias Vormehr; Juliane Quinkhardt; Thomas Bukur; Barbara Schrörs; Martin Löewer; Mustafa Diken; Özlem Türeci; Ugur Sahin; Sebastian Kreiter
Journal:  Oncoimmunology       Date:  2020-06-22       Impact factor: 8.110
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.